Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (101-110 of 252) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcomaJustin Stebbing, Adam Sanitt, Alastair Teague, et al.
Viral Immunology|June 30, 2012
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infectionSonia Norris, Adam Coleman, Leticia Kuri-Cervantes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control studyRachael Jones, Justin Stebbing, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2004
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)Justin Stebbing, Mark Nelson, Chloe Orkin, et al.
AIDS (London, England)|March 22, 2006
Do the mutations M046I and I047A confer resistance to kaletra?Huw Price, Rachael Jones, Milena Stevanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective studyJustin Stebbing, Laura Waters, Liz Davies, et al.
American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
Archives of Internal Medicine|September 24, 2008
Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomesRachael Jones, Mark Nelson, Mark Bower, et al.
Leukemia & Lymphoma|June 30, 2004
Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levelsTom Newsom-Davis, Mark Bower, Adrian Wildfire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Prospective stage-stratified approach to AIDS-related Kaposi's sarcomaMark Bower, Alessia Dalla Pria, Chris Coyle, et al.
Pageof 26

Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcomaJustin Stebbing, Adam Sanitt, Alastair Teague, et al.
Viral Immunology|June 30, 2012
PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infectionSonia Norris, Adam Coleman, Leticia Kuri-Cervantes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control studyRachael Jones, Justin Stebbing, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2004
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)Justin Stebbing, Mark Nelson, Chloe Orkin, et al.
AIDS (London, England)|March 22, 2006
Do the mutations M046I and I047A confer resistance to kaletra?Huw Price, Rachael Jones, Milena Stevanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective studyJustin Stebbing, Laura Waters, Liz Davies, et al.
American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
Archives of Internal Medicine|September 24, 2008
Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomesRachael Jones, Mark Nelson, Mark Bower, et al.
Leukemia & Lymphoma|June 30, 2004
Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levelsTom Newsom-Davis, Mark Bower, Adrian Wildfire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Prospective stage-stratified approach to AIDS-related Kaposi's sarcomaMark Bower, Alessia Dalla Pria, Chris Coyle, et al.
Pageof 26